Підписатись
Rafael de La Torre Fornell
Rafael de La Torre Fornell
Director del Instituto del Hospital del Mar de Investigaciones (IMIM), Profesor de Toxicología Asociado a la UPF
Підтверджена електронна адреса в upf.edu - Домашня сторінка
Назва
Посилання
Посилання
Рік
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial
MI Covas, K Nyyssönen, HE Poulsen, J Kaikkonen, HJF Zunft, ...
Annals of internal medicine 145 (5), 333-341, 2006
10122006
Mediterranean diet and age-related cognitive decline: a randomized clinical trial
C Valls-Pedret, A Sala-Vila, M Serra-Mir, D Corella, R De la Torre, ...
JAMA internal medicine 175 (7), 1094-1103, 2015
9412015
Benefits of the Mediterranean Diet: Insights From the PREDIMED Study
MA Martínez González, J Salas Salvadó, R Estruch, D Corella, M Fitó, ...
810*
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008
J López-Miranda, F Pérez-Jiménez, E Ros, R De Caterina, L Badimón, ...
Nutrition, metabolism and cardiovascular diseases 20 (4), 284-294, 2010
7262010
Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial
M Fitó, M Guxens, D Corella, G Sáez, R Estruch, R De La Torre, F Francés, ...
Archives of internal medicine 167 (11), 1195-1203, 2007
5562007
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
R De la Torre, M Farré, PN Roset, N Pizarro, S Abanades, M Segura, ...
Therapeutic drug monitoring 26 (2), 137-144, 2004
5222004
Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans
R De La Torre, M Farre, J Ortuno, M Mas, R Brenneisen, PN Roset, ...
British journal of clinical pharmacology 49 (2), 104-109, 2000
4922000
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans
M Mas, M Farré, R De la Torre, PN Roset, J Ortuño, J Segura, J Camí
Journal of Pharmacology and Experimental Therapeutics 290 (1), 136-145, 1999
4361999
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
P Pérez-Martínez, DP Mikhailidis, VG Athyros, M Bullo, P Couture, ...
Nutrition reviews 75 (5), 307-326, 2017
4202017
Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study
A Tresserra-Rimbau, EB Rimm, A Medina-Remón, MA Martínez-González, ...
Nutrition, Metabolism and Cardiovascular Diseases 24 (6), 639-647, 2014
3742014
International conference on the healthy effect of virgin olive oil
Jaen
European journal of clinical investigation 35 (7), 421-424, 2005
3532005
In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial
V Konstantinidou, MI Covas, D Muñoz‐Aguayo, O Khymenets, ...
The FASEB Journal 24 (7), 2546-2557, 2010
3382010
Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans
MI Covas, K de la Torre, M Farré-Albaladejo, J Kaikkonen, M Fitó, ...
Free Radical Biology and Medicine 40 (4), 608-616, 2006
3382006
Hydroxytyrosol disposition in humans
E Miro-Casas, MI Covas, M Farre, M Fito, J Ortuno, T Weinbrenner, ...
Clinical chemistry 49 (6), 945-952, 2003
3372003
Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men
T Weinbrenner, M Fito, R De La Torre, GT Saez, P Rijken, C Tormos, ...
The Journal of nutrition 134 (9), 2314-2321, 2004
3312004
Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial
M Fitó, M Cladellas, R De La Torre, J Marti, M Alcántara, ...
Atherosclerosis 181 (1), 149-158, 2005
3302005
Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation: a randomized controlled trial
J Marrugat, MI Covas, M Fitó, H Schröder, E Miró-Casas, E Gimeno, ...
European journal of nutrition 43, 140-147, 2004
3302004
Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.
D Sesardic, AR Boobis, BP Murray, S Murray, J Segura, R De La Torre, ...
British journal of clinical pharmacology 29 (6), 651-663, 1990
3301990
Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans
R De la Torre, S De Sola, M Pons, A Duchon, MM de Lagran, M Farré, ...
Molecular nutrition & food research 58 (2), 278-288, 2014
3282014
World‐Wide FINGERS Network: a global approach to risk reduction and prevention of dementia
M Kivipelto, F Mangialasche, HM Snyder, R Allegri, S Andrieu, H Arai, ...
Alzheimer's & dementia 16 (7), 1078-1094, 2020
3262020
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20